Please use this identifier to cite or link to this item:
Title: Treatment of xerostomia and hyposalivation in the elderly: A systematic review.
Authors: Gil-Montoya, J-A
Silvestre, F-J
Barrios, R
Silvestre-Rangil, J
metadata.dc.subject.mesh: Acupuncture Therapy
Head and Neck Neoplasms
Sjogren's Syndrome
Issue Date: 1-May-2016
Abstract: Therapeutic strategies for xerostomia, regardless of etiology, have so far not had definitive or clearly effective results. To systematically revise the latest scientific evidence available regarding the treatment of dry mouth, regardless of the cause of the problem. The literature search was conducted in March 2015, using the Medline and Embase databases. The "Clinical Trial", from 2006 to March 2015, was carried out in English and only on human cases. The draft of the systematic review and assessment of the methodological quality of the trials was carried out following the criteria of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the "Oxford Quality Scale". Finally, a total of 26 trials were identified that met the previously defined selection and quality criteria; 14 related to drug treatments for dry mouth, 10 with non-pharmacological treatment and 2 with alternative treatments. Pilocarpine continues to be the best performing sialogogue drug for subjects with xerostomia due to radiation on head and neck cancer or diseases such as Sjogren's Syndrome. For patients with dry mouth caused solely by medication, there are some positive indications from the use of malic acid, along with other elements that counteract the harmful effect on dental enamel. In general, lubrication of oral mucous membrane reduces the symptoms, although the effects are short-lived.
metadata.dc.identifier.doi: 10.4317/medoral.20969
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC4867210.pdf955,25 kBAdobe PDFView/Open

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.